Lion Point Capital, LP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lion Point Capital, LP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$22,045,000
-21.1%
1,160,307
+38.3%
5.91%
+12.9%
Q3 2021$27,926,000
+18.2%
839,128
+37.8%
5.24%
+28.2%
Q2 2021$23,628,000
-19.5%
609,1280.0%4.08%
-23.6%
Q1 2021$29,359,000
-57.5%
609,128
-54.1%
5.34%
-59.8%
Q4 2020$69,068,000
+94.4%
1,327,7340.0%13.30%
+70.7%
Q3 2020$35,530,000
+103.2%
1,327,734
+47.9%
7.79%
+83.7%
Q2 2020$17,489,000897,7994.24%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
RA Capital Management 6,880,323$38,633,0002.30%
Eversept Partners, LP 773,501$4,343,2081.35%
Opaleye Management Inc. 612,500$3,439,0001.24%
BRIDGER MANAGEMENT, LLC 2,334,196$13,107,0001.08%
Sofinnova Investments, Inc. 1,733,628$9,734,0000.88%
PURA VIDA INVESTMENTS, LLC 354,719$1,992,0000.34%
683 Capital Management, LLC 400,000$2,246,0000.25%
NEXPOINT ASSET MANAGEMENT, L.P. 649,460$3,646,0000.23%
Artal Group S.A. 900,000$5,054,0000.20%
Frontier Wealth Management LLC 226,750$1,273,0000.19%
View complete list of TG THERAPEUTICS INC shareholders